Companies

Covidien is showcasing some of its most innovative surgical products at the American College of Surgeons (ACS) annual clinical congress being held at McCormick Place in Chicago this week. Key featured products include the new Sonicision™ ultrasonic incision and hemostasis device as well as the company’s iDrive™ Ultra powered stapling system.

Stryker Corporation’s Board of Directors announced today that Kevin A. Lobo has been named the Company’s President and Chief Executive Officer, effective immediately. He has also been named to the Company’s Board of Directors. Mr. Lobo joined Stryker in April 2011, and was most recently Group President of Stryker Orthopaedics.

Orthopaedic and Sports Med company DePuy Mitek, Inc., has announced the launch of the Healix Advance™ Family of Suture Anchors, a comprehensive new system of rotator cuff anchor and instrumentation solutions. The company says its new anchor design will enable faster insertion into hard bone and maximise fixation and pull-out strength.

Medtronic, Inc. and China Kanghui Holdings announced today that they have entered into a merger agreement whereby Medtronic will acquire Kanghui. The agreement calls for Medtronic to pay approximately $816 million in cash.

It’s looking like Boston Scientific Week with more news about launches or approvals. The FDA has approved Boston’s S-ICD® System, which we seem to remember triggers a big fat earn-out payment to Cameron Health following its acquisition earlier this year.

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration clearance for the Emerge™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Dilatation Catheter and has begun marketing the device in the United States. The Emerge Catheter is a next-generation pre-dilatation balloon catheter designed specifically to offer exceptional deliverability for physicians to address challenging lesions in coronary arteries. Both the Monorail® and Over-The-Wire (OTW) options are available. The Emerge Catheter has been commercially available in CE Mark countries since earlier this year.
PR Newswire (http://s.tt/1ov7B)

Boston Scientific Corporation has received CE Mark approval for use of its Vercise™ Deep Brain Stimulation System for the treatment of Parkinson’s disease. The company says this is the first and only commercially available DBS system to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain.

Cook Medical has today announced a major development in the extension of its European operations with the opening of a new €15m distribution center in Baesweiler, Germany.

InspireMD, Inc. has announced that Ofir Paz, co-founder, board member and Chief Executive Officer of InspireMD since its founding in 2005, intends to step down as CEO as part of a planned transition to prepare the Company for formal commercialisation of its proprietary MGuard™ Embolic Protection Stent (EPS) platform technology for patients with Acute Myocardial Infarction.

Orthopaedic and Sport Med device company DePuy Mitek, Inc.has announced the launch of Endurance Hip Solutions, a new system of instruments and devices that marks the company’s entry into the rapidly growing field of hip arthroscopy.

Medtronic announces CE mark for CoreValve® Evolut™, incorporating features designed for optimal fit. With the new 23mm iteration, Medtronic claims its CoreValve family treats the broadest range of patient valve sizes.

On June 5, 2012, Stryker initiated a Class 1 recall of the Neptune Waste Management System. Now that recall has been expanded to other iterations of the device because it appears they have been marketed without 510(k) clearance which FDA deems necessary in order to establish their safety and efficacy.

Abbott says the potential long-term benefits of a scaffold that dissolves are significant and include a return of vessel function. CE mark and approval in many other countries sees availability widen for this first-in-class solution.

Medtronic, Inc. has announced CE Mark for its new Affinity Fusion® oxygenation system, opening the door to a European launch. The system, which oxygenates and removing carbon dioxide from blood during various open-heart surgical procedures, incorporates numerous innovations for claimed patient safety and ease of use.

Reliance® 4-Front™ Lead is designed to streamline surgical procedure for implantation of ICDs by improving handling and simplifying implantation.

St. Jude Medical, Inc. has announced it has received European CE Mark approval of its Eon™ family of neurostimulators for patients with intractable chronic migraine. The range includes the Eon Mini, which St.Jude says is the world’s smallest rechargeable neurostimulator with the longest-lasting battery in its class.